Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Emerging Role of Benzimidazole-Loaded Nanoparticles in Targeted Drug Delivery and Cancer Therapy: A review
View through CrossRef
Benzimidazole derivatives are a privileged heterocyclic scaffold with well-established pharmacological activities, including antimicrobial, antiviral, and anticancer properties. Despite their therapeutic promise, many benzimidazole compounds face challenges such as poor aqueous solubility, limited bioavailability, and off-target toxicity, which hinder their clinical translation. Recent advances in nanotechnology have provided innovative solutions to these limitations through the development of benzimidazole-loaded nanoparticles. Nanoparticle-based formulations improve the solubility, stability and pharmacokinetic profile of benzimidazoles while enabling targeted and sustained delivery to tumor tissues. This review provides a comprehensive analysis of the emerging role of benzimidazole-loaded nanoparticles in drug delivery and cancer therapy. It covers the pharmacological significance of benzimidazoles, nanocarrier platforms, targeting mechanisms, preclinical evidence, clinical outlook, challenges, and future perspectives. Emphasis is placed on how nanotechnology enhances the therapeutic performance of benzimidazoles through improved bioavailability, tumor targeting via passive and active strategies, and controlled drug release.
Title: Emerging Role of Benzimidazole-Loaded Nanoparticles in Targeted Drug Delivery and Cancer Therapy: A review
Description:
Benzimidazole derivatives are a privileged heterocyclic scaffold with well-established pharmacological activities, including antimicrobial, antiviral, and anticancer properties.
Despite their therapeutic promise, many benzimidazole compounds face challenges such as poor aqueous solubility, limited bioavailability, and off-target toxicity, which hinder their clinical translation.
Recent advances in nanotechnology have provided innovative solutions to these limitations through the development of benzimidazole-loaded nanoparticles.
Nanoparticle-based formulations improve the solubility, stability and pharmacokinetic profile of benzimidazoles while enabling targeted and sustained delivery to tumor tissues.
This review provides a comprehensive analysis of the emerging role of benzimidazole-loaded nanoparticles in drug delivery and cancer therapy.
It covers the pharmacological significance of benzimidazoles, nanocarrier platforms, targeting mechanisms, preclinical evidence, clinical outlook, challenges, and future perspectives.
Emphasis is placed on how nanotechnology enhances the therapeutic performance of benzimidazoles through improved bioavailability, tumor targeting via passive and active strategies, and controlled drug release.
Related Results
SYNTHESIS AND POTENTIAL BIOLOGICAL ACTIVITY OF ANALOGUES OF THE DIBAZOL
SYNTHESIS AND POTENTIAL BIOLOGICAL ACTIVITY OF ANALOGUES OF THE DIBAZOL
The synthesis of benzimidazole derivatives, similar to dibazole, was carried out using two methods. According to the first, 1, 2-Phenylenediamine condensed with excess quantity of ...
Antimicrobial activity of ciprofloxacin-coated gold nanoparticles on selected pathogens
Antimicrobial activity of ciprofloxacin-coated gold nanoparticles on selected pathogens
Antibiotic resistance amongst bacterial pathogens is a crisis that has been worsening over recent decades, resulting in serious and often fatal infections that cannot be treated by...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
The Promise of Exosomes as Drug Delivery Systems
The Promise of Exosomes as Drug Delivery Systems
Exosomes are small extracellular vesicles that play a role in cell-to-cell communication by transferring bioactive molecules such as proteins, nucleic acids, and lipids between cel...
Benzimidazole Derivatives in Breast Cancer: Target-Specific Therapeutic Breakthroughs
Benzimidazole Derivatives in Breast Cancer: Target-Specific Therapeutic Breakthroughs
Despite ongoing advancements in drug design and developments, breast cancer remains
a serious and devastating disease and is ranked as the second most common illness in women.
Brea...
Targeted delivery of doxorubicin
Targeted delivery of doxorubicin
<p>Cancer is a group of diseases caused by uncontrolled cellular proliferation and dissemination. After heart disease, cancer is the second most common cause of death in the ...
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
Selection of Injectable Drug Product Composition using Machine Learning Models (Preprint)
BACKGROUND
As of July 2020, a Web of Science search of “machine learning (ML)” nested within the search of “pharmacokinetics or pharmacodynamics” yielded over 100...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...